Shares of ImmunoGen dropped 5.32% to $7.65 at 15:26 EST on Tuesday, after two consecutive sessions in a row of gains. NASDAQ Composite is falling 2.31% to $13,574.72, after two successive sessions in a row of losses. This seems, up until now, an all-around rough trend trading session today.
ImmunoGen’s last close was $8.08, 42.22% under its 52-week high of $10.88.
ImmunoGen’s sales growth is 33.4% for the present quarter and 34.9% for the next. The company’s growth estimates for the present quarter and the next is a negative 11.8% and a negative 28.6%, respectively.
Year-on-year quarterly revenue growth grew by 91.2%, now sitting on 132.3M for the twelve trailing months.
ImmunoGen’s Stock Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $7.65 at 15:26 EST, way under its 52-week high of $10.88 and way above its 52-week low of $3.34.
ImmunoGen’s Moving Average
ImmunoGen’s worth is way under its 50-day moving average of $8.73 and way higher than its 200-day moving average of $6.76.
More news about ImmunoGen.